Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 3Phase 1 3Phase 1/2 1

Status

Completed 49Recruiting 19Terminated 9Active not recruiting 9Withdrawn 7Unknown 3Not yet recruiting 3Suspended 2

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 33Leukemia, Myeloid, Acute 26Colorectal Neoplasms 26Neoplasms 24Neoplasm Metastasis 23Recurrence 22Multiple Myeloma 22Advanced Solid Tumors 19Lymphoma, B-Cell 18Breast Neoplasms 18Lung Neoplasms 14Pancreatic Neoplasms 13Glioblastoma 13Melanoma 12Hematologic Neoplasms 12Carcinoma, Hepatocellular 12Lymphoma 11Glioma 11Brain Neoplasms 11Squamous Cell Carcinoma of Head and Neck 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Leukemia 10Advanced Solid Tumor 10Prostatic Neoplasms 9Ovarian Neoplasms 9Head and Neck Neoplasms 9Triple Negative Breast Neoplasms 8Lymphoma, Non-Hodgkin 8Lymphoma, Large B-Cell, Diffuse 8Esophageal Neoplasms 8

Interventions

anlotinib 1Epirubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Not yet recruiting × Osteosarcoma × Clear all
NCT07211737 2026-02-06

NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma

Baylor College of Medicine

Phase 1 Not yet recruiting
27 enrolled
CNSSarcoma

Neuroblastoma, Osteosarcoma

NCT06699576 2024-11-21

ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma.

Hansoh BioMedical R&D Company

Phase 1 Not yet recruiting
448 enrolled
Sarcoma

Sarcoma, Osteosarcoma

NCT06412458 2024-05-14

IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma

Beijing Immunochina Medical Science & Technology Co., Ltd.

Phase 1 Not yet recruiting
9 enrolled
Sarcoma

Recurrence, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡